» Articles » PMID: 15528047

Redox-dependent Effects of Nitric Oxide on Microvascular Integrity in Oxygen-induced Retinopathy

Overview
Date 2004 Nov 6
PMID 15528047
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Opposing effects have been ascribed to nitric oxide (NO) on retinal microvascular survival. We investigated whether changes in the redox state may contribute to explain apparent conflicting actions of NO in a model of oxygen-induced retinal vasoobliteration. Retinal microvascular obliteration was induced by exposing 7-day-old rat pups (P7) for 2 or 5 days to 80% O(2). The redox state of the retina was assessed by measuring reduced glutathione and oxidative and nitrosative products malondialdehyde and nitrotyrosine. The role of NO on vasoobliteration was evaluated by treating animals with nitric oxide synthase (NOS) inhibitors (N-nitro-l-arginine; L-NA) and by determining NOS isoform expression and activity; the contribution of nitrosative stress was also determined in animals treated with the degradation catalyst of peroxynitrite FeTPPS or with the superoxide dismutase mimetic CuDIPS. eNOS, but not nNOS or iNOS, expression and activity were increased throughout the exposure to hyperoxia. These changes were associated with an early (2 days hyperoxia) decrease in reduced glutathione and increases in malondialdehyde and nitrotyrosine. CuDIPS, FeTPPS, and L-NA treatments for these 2 days of hyperoxia nearly abolished the vasoobliteration. In contrast, during 5 days exposure to hyperoxia when the redox state rebalanced, L-NA treatment aggravated the vasoobliteration. Interestingly, VEGFR-2 expression was respectively increased by NOS inhibition after short-term (2 days) exposure to hyperoxia and decreased during the longer hyperoxia exposure. Data disclose that the dual effects of NO on newborn retinal microvascular integrity in response to hyperoxia in vivo depend on the redox state and seem mediated at least in part by VEGFR-2.

Citing Articles

Oxidative Stress Implication in Retinal Diseases-A Review.

Nebbioso M, Franzone F, Lambiase A, Bonfiglio V, Limoli P, Artico M Antioxidants (Basel). 2022; 11(9).

PMID: 36139862 PMC: 9495599. DOI: 10.3390/antiox11091790.


3β-Hydroxy-5β-hydroxy-B-norcholestane-6β-carboxaldehyde (SEC-B) Induces Proinflammatory Activation of Human Endothelial Cells Associated with Nitric Oxide Production and Endothelial Nitric Oxide Synthase/Caveolin-1 Dysregulation.

Nasoni M, Benedetti S, Crinelli R, Palma F, Canonico B, Monittola F Antioxidants (Basel). 2022; 11(6).

PMID: 35740044 PMC: 9220016. DOI: 10.3390/antiox11061148.


Oxidative Stress Markers and the Retinopathy of Prematurity.

Graziosi A, Perrotta M, Russo D, Gasparroni G, DEgidio C, Marinelli B J Clin Med. 2020; 9(9).

PMID: 32825796 PMC: 7563779. DOI: 10.3390/jcm9092711.


Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity.

Tsang J, Liu J, Lo A Int J Mol Sci. 2019; 20(17).

PMID: 31484463 PMC: 6747312. DOI: 10.3390/ijms20174321.


Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study.

Filippi L, Cavallaro G, Berti E, Padrini L, Araimo G, Regiroli G Front Pediatr. 2019; 7:180.

PMID: 31134171 PMC: 6514240. DOI: 10.3389/fped.2019.00180.